Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Elvitegravir 150mg tablets
0503010AJAAABAB
|
Elvitegravir | Elvitegravir | Infections | No data available |
|
Elvitegravir 85mg tablets
0503010AJAAAAAA
|
Elvitegravir | Elvitegravir | Infections | No data available |
|
Elvitegravir 90mg/Cobicistat/Emtr/Tenofovir alafenamide tab
0503010BAAAAAAA
|
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide | Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide | Infections | No data available |
|
Emtricitabine 10mg/ml oral solution sugar free
0503010K0AAABAB
|
Emtricitabine | Emtricitabine | Infections | No data available |
|
Emtricitabine 200mg capsules
0503010K0AAAAAA
|
Emtricitabine | Emtricitabine | Infections | No data available |
|
Emtriva 10mg/ml oral solution
0503010K0BBABAB
|
Emtriva | Emtricitabine | Infections | No data available |
|
Emtriva 200mg capsules
0503010K0BBAAAA
|
Emtriva | Emtricitabine | Infections | No data available |
|
Enfuvirtide 108mg inj vials
0503010J0AAAAAA
|
Enfuvirtide | Enfuvirtide | Infections | No data available |
|
Epivir 150mg tablets
0503010Q0BBAAAA
|
Epivir | Lamivudine | Infections | No data available |
|
Epivir 300mg tablets
0503010Q0BBACAE
|
Epivir | Lamivudine | Infections | No data available |
|
Epivir 50mg/5ml oral solution
0503010Q0BBABAB
|
Epivir | Lamivudine | Infections | No data available |
|
Ergamisol 50mg tablets
0505020L0BCAAAB
|
Ergamisol | Levamisole hydrochloride | Infections | No data available |
|
Erythrocin IV lactobionate 1g inf vials
0501050K0BBAAAA
|
Erythrocin (Parenteral) | Erythromycin lactobionate | Infections | No data available |
|
Erythrolar 250mg tablets
0501050N0BCAAAA
|
Erythrolar (Tablet) | Erythromycin stearate | Infections | No data available |
|
Erythrolar 500mg tablets
0501050N0BCABAB
|
Erythrolar (Tablet) | Erythromycin stearate | Infections | No data available |
|
Erythromycin 1g powder for solution for infusion vials
0501050K0AAAAAA
|
Erythromycin lactobionate (Parent) | Erythromycin lactobionate | Infections | No data available |
|
Eskazole 400mg tablets
0505030A0BBABAD
|
Eskazole | Albendazole | Infections | No data available |
|
Ethambutol 100mg/5ml oral solution
0501090H0AABDBD
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 125mg/5ml oral solution
0501090H0AABFBF
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 150mg/5ml oral solution
0501090H0AABCBC
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 150mg/5ml oral suspension
0501090H0AABHBH
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 200mg/5ml oral liquid
0501090H0AAAVAV
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 250mg/5ml oral liquid
0501090H0AABABA
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 25mg/5ml oral solution
0501090H0AAAWAW
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 350mg/5ml oral solution
0501090H0AAAYAY
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.